These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevention and control of biofilm-based medical-device-related infections. Francolini I; Donelli G FEMS Immunol Med Microbiol; 2010 Aug; 59(3):227-38. PubMed ID: 20412300 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of bacterial adhesion on medical devices. Rodrigues LR Adv Exp Med Biol; 2011; 715():351-67. PubMed ID: 21557075 [TBL] [Abstract][Full Text] [Related]
4. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Monteiro DR; Gorup LF; Takamiya AS; Ruvollo-Filho AC; de Camargo ER; Barbosa DB Int J Antimicrob Agents; 2009 Aug; 34(2):103-10. PubMed ID: 19339161 [TBL] [Abstract][Full Text] [Related]
5. Efficient surface modification of biomaterial to prevent biofilm formation and the attachment of microorganisms. Bazaka K; Jacob MV; Crawford RJ; Ivanova EP Appl Microbiol Biotechnol; 2012 Jul; 95(2):299-311. PubMed ID: 22618687 [TBL] [Abstract][Full Text] [Related]
7. Nanostructured selenium for preventing biofilm formation on polycarbonate medical devices. Wang Q; Webster TJ J Biomed Mater Res A; 2012 Dec; 100(12):3205-10. PubMed ID: 22707390 [TBL] [Abstract][Full Text] [Related]
8. The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections. Tamilvanan S; Venkateshan N; Ludwig A J Control Release; 2008 May; 128(1):2-22. PubMed ID: 18342974 [TBL] [Abstract][Full Text] [Related]
13. Bacterial adherence and biofilm formation on medical implants: a review. Veerachamy S; Yarlagadda T; Manivasagam G; Yarlagadda PK Proc Inst Mech Eng H; 2014 Oct; 228(10):1083-99. PubMed ID: 25406229 [TBL] [Abstract][Full Text] [Related]
14. Biofilm formation on dental restorative and implant materials. Busscher HJ; Rinastiti M; Siswomihardjo W; van der Mei HC J Dent Res; 2010 Jul; 89(7):657-65. PubMed ID: 20448246 [TBL] [Abstract][Full Text] [Related]
15. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance? Gilbert P; Allison DG; McBain AJ J Appl Microbiol; 2002; 92 Suppl():98S-110S. PubMed ID: 12000619 [TBL] [Abstract][Full Text] [Related]
16. Sustained prevention of biofilm formation on a novel silicone matrix suitable for medical devices. Steffensen SL; Vestergaard MH; Groenning M; Alm M; Franzyk H; Nielsen HM Eur J Pharm Biopharm; 2015 Aug; 94():305-11. PubMed ID: 26028273 [TBL] [Abstract][Full Text] [Related]
17. Biofilms: recent developments on an old battle. de Carvalho CC Recent Pat Biotechnol; 2007; 1(1):49-57. PubMed ID: 19075832 [TBL] [Abstract][Full Text] [Related]
18. Assessment of biofilm cell removal and killing and biocide efficacy using the microtiter plate test. Shakeri S; Kermanshahi RK; Moghaddam MM; Emtiazi G Biofouling; 2007; 23(1-2):79-86. PubMed ID: 17453732 [TBL] [Abstract][Full Text] [Related]
19. Escherichia coli serotype O157:H7 retention on solid surfaces and peroxide resistance is enhanced by dual-strain biofilm formation. Uhlich GA; Rogers DP; Mosier DA Foodborne Pathog Dis; 2010 Aug; 7(8):935-43. PubMed ID: 20367070 [TBL] [Abstract][Full Text] [Related]
20. Adaptation of Campylobacter jejuni to biocides used in the food industry affects biofilm structure, adhesion strength, and cross-resistance to clinical antimicrobial compounds. Techaruvichit P; Takahashi H; Kuda T; Miya S; Keeratipibul S; Kimura B Biofouling; 2016 Aug; 32(7):827-39. PubMed ID: 27353218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]